company background image
QDEL logo

QuidelOrtho NasdaqGS:QDEL Stock Report

Last Price

US$43.77

Market Cap

US$2.9b

7D

-3.9%

1Y

-38.6%

Updated

06 Oct, 2024

Data

Company Financials +

QuidelOrtho Corporation

NasdaqGS:QDEL Stock Report

Market Cap: US$2.9b

QuidelOrtho Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for QuidelOrtho
Historical stock prices
Current Share PriceUS$43.77
52 Week HighUS$75.86
52 Week LowUS$29.74
Beta0.087
11 Month Change0.74%
3 Month Change44.17%
1 Year Change-38.59%
33 Year Change-68.29%
5 Year Change-24.08%
Change since IPO157.47%

Recent News & Updates

QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

Sep 15
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

Aug 09
QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

Recent updates

QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

Sep 15
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

Aug 09
QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

QuidelOrtho: Attractive Valuation Despite Weak Performance

Apr 13

We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

Apr 08
We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

Feb 15
QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate

Mar 13
QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate

QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Feb 18
QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued

Nov 25
An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued

QuidelOrtho forecasts strong Q3 revenue above estimates, shares rise ~6% after hours

Oct 12

QuidelOrtho: Fundamentals Remain, Upbeat Financials

Sep 14

Improved Earnings Required Before QuidelOrtho Corporation (NASDAQ:QDEL) Shares Find Their Feet

Sep 03
Improved Earnings Required Before QuidelOrtho Corporation (NASDAQ:QDEL) Shares Find Their Feet

QuidelOrtho announces $300M share repurchase authorization

Aug 17

Robust Earnings May Not Tell The Whole Story For QuidelOrtho (NASDAQ:QDEL)

Aug 13
Robust Earnings May Not Tell The Whole Story For QuidelOrtho (NASDAQ:QDEL)

Quidel Non-GAAP EPS of $2.34 misses by $0.51, revenue of $613.4M misses by $27.21M

Aug 04

QuidelOrtho: Continuing Its Upward Ascent

Jul 08

Calculating The Fair Value Of QuidelOrtho Corporation (NASDAQ:QDEL)

Jun 01
Calculating The Fair Value Of QuidelOrtho Corporation (NASDAQ:QDEL)

Shareholder Returns

QDELUS Medical EquipmentUS Market
7D-3.9%-1.1%0.4%
1Y-38.6%20.8%32.6%

Return vs Industry: QDEL underperformed the US Medical Equipment industry which returned 20.8% over the past year.

Return vs Market: QDEL underperformed the US Market which returned 32.6% over the past year.

Price Volatility

Is QDEL's price volatile compared to industry and market?
QDEL volatility
QDEL Average Weekly Movement6.5%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.4%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: QDEL has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: QDEL's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19797,100Brian Blaserwww.quidelortho.com

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

QuidelOrtho Corporation Fundamentals Summary

How do QuidelOrtho's earnings and revenue compare to its market cap?
QDEL fundamental statistics
Market capUS$2.94b
Earnings (TTM)-US$1.86b
Revenue (TTM)US$2.83b

1.0x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QDEL income statement (TTM)
RevenueUS$2.83b
Cost of RevenueUS$1.48b
Gross ProfitUS$1.36b
Other ExpensesUS$3.22b
Earnings-US$1.86b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-27.66
Gross Margin47.89%
Net Profit Margin-65.60%
Debt/Equity Ratio80.8%

How did QDEL perform over the long term?

See historical performance and comparison